EUVIMEDEUVIMED entdecken
Crossref

Sustainable UV–spectrophotometric analysis of meloxicam and Rizatriptan in newly FDA-approved tablets using Fedorov algorithm–optimized regression, learning, and MCR-ALS resolution-based models with MA and NQS assessment

Omkulthom Al kamaly, Lateefa A. Al- Khateeb, Michael K. Halim, Galal Magdy, Raghda A. Emam, Ahmed Emad F. Abbas

Microchemical Journal · 2025-12 · 219 · 116041

DOI: 10.1016/j.microc.2025.116041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchemical Journal, 2025-12. Verfasst von Omkulthom Al kamaly und 5 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Princess Nourah Bint Abdulrahman University, Princess Nourah bint Abdulrahman University Deanship of Scientific Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Princess Nourah Bint Abdulrahman University
  • Princess Nourah bint Abdulrahman University Deanship of Scientific Research

Zitieren

APA

kamaly, O. A., Khateeb, L. A. A., Halim, M. K., Magdy, G., Emam, R. A., & Abbas, A. E. F. (2025). Sustainable UV–spectrophotometric analysis of meloxicam and Rizatriptan in newly FDA-approved tablets using Fedorov algorithm–optimized regression, learning, and MCR-ALS resolution-based models with MA and NQS assessment. Microchemical Journal, 219, 116041. https://doi.org/10.1016/j.microc.2025.116041

Vancouver

kamaly OA, Khateeb LAA, Halim MK, Magdy G, Emam RA, Abbas AEF. Sustainable UV–spectrophotometric analysis of meloxicam and Rizatriptan in newly FDA-approved tablets using Fedorov algorithm–optimized regression, learning, and MCR-ALS resolution-based models with MA and NQS assessment. Microchemical Journal. 2025;219:116041. doi:10.1016/j.microc.2025.116041

BibTeX
@article{kamaly2025,
  author = {kamaly, Omkulthom Al and Khateeb, Lateefa A. Al- and Halim, Michael K. and Magdy, Galal and Emam, Raghda A. and Abbas, Ahmed Emad F.},
  title = {Sustainable UV–spectrophotometric analysis of meloxicam and Rizatriptan in newly FDA-approved tablets using Fedorov algorithm–optimized regression, learning, and MCR-ALS resolution-based models with MA and NQS assessment},
  journal = {Microchemical Journal},
  year = {2025},
  volume = {219},
  pages = {116041},
  doi = {10.1016/j.microc.2025.116041}
}
Kostenlos starten →